The Patent Finder

Conatus Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Conatus Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Conatus Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 6,790,989Inhibitors of the ICE/ced-3 family of cysteine proteases
Term ended
Ended no later than Jan 26, 2021 · From the USPTO record
Term endedEnded no later than Jan 26, 2021From the USPTO record
US 6,762,045Membrane derived caspase-3, compositions comprising the same and methods of use therefor
Term ended
Term ended Nov 20, 2020 · From the USPTO record
Term endedTerm ended Nov 20, 2020From the USPTO record
US 7,053,056C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
Term ended
Term ended Apr 8, 2020 · From the USPTO record
Term endedTerm ended Apr 8, 2020From the USPTO record
US 7,183,260C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
Term ended
Term ended Oct 23, 2018 · From the USPTO record
Term endedTerm ended Oct 23, 2018From the USPTO record
US 6,197,750C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
Term ended
Term ended Oct 22, 2018 · From the USPTO record
Term endedTerm ended Oct 22, 2018From the USPTO record
US 6,544,951C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
Term ended
Ended no later than Oct 22, 2018 · From the USPTO record
Term endedEnded no later than Oct 22, 2018From the USPTO record
US 6,824,991Human bad polypeptides, encoding nucleic acids and methods of use
Term ended
Term ended Jun 2, 2018 · From the USPTO record
Term endedTerm ended Jun 2, 2018From the USPTO record
US 6,693,096Treatment of inflammation-associated disorders using interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family inhibitors
Term ended
Term ended Nov 29, 2017 · From the USPTO record
Term endedTerm ended Nov 29, 2017From the USPTO record
US 6,610,683Treatment of infectious disease using interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family inhibitors
Term ended
Term ended Oct 13, 2017 · From the USPTO record
Term endedTerm ended Oct 13, 2017From the USPTO record
US 6,200,969Inhibition of apoptosis using interleukin-1.beta.-converting enzyme (ICE)/CED-3 family inhibitors
Term ended
Term ended Sep 12, 2017 · From the USPTO record
Term endedTerm ended Sep 12, 2017From the USPTO record
10 of 22 patents shown.
Pro members see all 22.
Pro members: see all 22 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited